ClassID:

109227

C12N2320/50 - CPC Classification

Classification description:

Applications; Uses Methods for regulating/modulating their activity

Sub-classes:
Recent Application in this class:
#1
20260159856
2026-06-11

Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing

#2
20260028639
2026-01-29

PLANT REGULATORY ELEMENTS AND USES THEREOF

#3
20250368993
2025-12-04

Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof

#4
20250339457
2025-11-06

METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION

#5
20250333737
2025-10-30

17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#6
20250313831
2025-10-09

SEQUENCE DETERMINANTS OF DSRNA PROCESSING BY DICER

#7
20250304962
2025-10-02

STEREOSPECIFIC LINKAGES IN RNA EDITING OLIGONUCLEOTIDES

#8
20250276060
2025-09-04

SELECTIVELY ALTERING MICROBIOTA FOR IMMUNE MODULATION

#9
20250270609
2025-08-28

TOEHOLD EXCHANGE RIBOREGULATOR GATE AND REGULATING PROTEIN TRANSLATION WITH TOEHOLD EXCHANGE RIBOREGULATOR

#10
20250101422
2025-03-27

METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT

#11
20250011785
2025-01-09

Compositions and Methods for Modulating Single Stranded DNA Regions that Catalyze Enzymatic Reactions

#12
20250011756
2025-01-09

METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS

#13
20240384269
2024-11-21

COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSIOCHEMICAL CHARACTERISTICS

#14
20240376462
2024-11-14

ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS

#15
20240336925
2024-10-10

Riboswitch modulated gene therapy for retinal diseases

#16
20240287537
2024-08-29

PLANT REGULATORY ELEMENTS AND USES THEREOF

#17
20240247261
2024-07-25

miRNA Switches for RNA-Triggered Control of RNA Interference

#18
20240158800
2024-05-16

RIBOSWITCH MODULATED GENE THERAPY FOR RETINAL DISEASES

#19
20240067964
2024-02-29

METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION

#20
20240026385
2024-01-25

ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS

#21
20240016937
2024-01-18

COMPOSITION CONTAINING NUCLEIC ACID MOLECULE STABLY

#22
20240011029
2024-01-11

MODIFIED OLIGONUCLEOTIDES FOR USE IN TREATMENT OF TAUOPATHIES

#23
20230416696
2023-12-28

Modified DAAO enzyme and application thereof

#24
20230407308
2023-12-21

CONDITIONAL-SIRNAS AND USES THEREOF IN TREATING ACUTE MYELOID LEUKEMIA

#25
20230399635
2023-12-14

RNA-Editing Compositions and Methods of Use

#26
20230265425
2023-08-24

lncRNA-REGULATED GENE EXPRESSION SYSTEM

#27
20230257781
2023-08-17

Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing

#28
20230248822
2023-08-10

Selectively altering microbiota for immune modulation

#29
20230242928
2023-08-03

MODULATING NUCLEOTIDE EXPRESSION USING EXPRESSION MODULATING ELEMENTS AND MODIFIED TATA AND USE THEREOF

#30
20230235346
2023-07-27

Synthetic ethylene-responsive binding element and uses thereof

#31
20230220402
2023-07-13

USE OF AN ORPHAN MOTIF TO INCREASE EXPRESSION OF A HETEROLOGOUS TRANSGENE

#32
20230220393
2023-07-13

METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT

#33
20230121967
2023-04-20

Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof

#34
20230054437
2023-02-23

Engineered class 2 type V CRISPR systems

#35
20230045516
2023-02-09

BIOACTIVE GLASS AS NUCLEIC ACID CARRIERS WITH PH SWITCH CONTROL-RELEASING

#36
20220403392
2022-12-22

APTAMER NANOFIBERS AND KILL-SWITCHES AND USES THEREOF

#37
20220333086
2022-10-20

Modified DAAO enzyme and application thereof

#38
20220307008
2022-09-29

METHOD FOR STABILIZING INTRACELLULAR RNA

#39
20220290111
2022-09-15

NUCLEIC ACIDS, PROTEINS AND PROCESSES FOR PRODUCING AMIDES

#40
20220275350
2022-09-01

CIRCULARLY PERMUTATED HALOALKANE TRANSFERASE FUSION MOLECULES

#41
20220204969
2022-06-30

COMPOSITIONS AND METHODS FOR RAPID AND DYNAMIC FLUX CONTROL USING SYNTHETIC METABOLIC VALVES

#42
20220002753
2022-01-06

SYSTEMS AND METHODS FOR POLYNUCLEOTIDE SPATIAL ORGANIZATION

#43
20210380985
2021-12-09

17ß-Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof

#44
20210348175
2021-11-11

Genetic toolbox for metabolic engineering of non-conventional yeast

#45
20210348166
2021-11-11

IMMUNOTHERAPY OF CANCER

#46
20210332378
2021-10-28

Plant regulatory elements and uses thereof

#47
20210310016
2021-10-07

Nitrogen responsive transcription factors in plants

#48
20210259218
2021-08-26

Methods of genetic mediated engineering of RNAi models

#49
20210230590
2021-07-29

Stereospecific linkages in RNA editing oligonucleotides

#50
20210171945
2021-06-10

METHODS OF MODULATING ANTISENSE ACTIVITY

#51
20210162066
2021-06-03

RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF

#52
20210147837
2021-05-20

Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof

#53
20210130819
2021-05-06

Increasing RNAi efficiency through single nucleotide mismatches

#54
20210123060
2021-04-29

Conditional-siRNAS and uses thereof in treating acute myeloid leukemia

#55
20210113689
2021-04-22

Selectively altering microbiota for immune modulation

#56
20210108220
2021-04-15

Simultaneous gene silencing and suppressing gene silencing in ihe same cell

#57
20210095284
2021-04-01

Modified oligonucleotides for use in treatment of tauopathies

#58
20210095272
2021-04-01

RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION

#59
20210079391
2021-03-18

Antisense oligonucleotide compositions

#60
20210017521
2021-01-21

Inhibitors of micro-RNA 22

#61
20210017520
2021-01-21

Micro-RNA and obesity

#62
20210002643
2021-01-07

Methods and compositions for modulating apolipoprotein (a) expression

#63
20200386741
2020-12-10

Method for inhibiting the expression of inflammation promoting factors

#64
20200362343
2020-11-19

METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT

#65
20200347388
2020-11-05

Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves

#66
20200339980
2020-10-29

High Specificity Genome Editing Using Chemically Modified Guide RNAs

#67
20200308258
2020-10-01

Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis

#68
20200299687
2020-09-24

Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves

#69
20200299686
2020-09-24

Methods and Compositions for Engineering Synthetic Bioswitches for Remote Control of Biological Activity

#70
20200063137
2020-02-27

Riboswitch modulated gene therapy for retinal diseases

#71
20200032261
2020-01-30

Methods and compositions for controlling efficacy of RNA silencing

#72
20200032254
2020-01-30

Antisense antibacterial compounds and methods

#73
20200031950
2020-01-30

Lin28-mediated control of let-7 biogenesis

#74
20200024602
2020-01-23

METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF SINGLE AND DOUBLE BLUNT-ENDED siRNA

#75
20190367948
2019-12-05

Orthogonal Cas9 proteins for RNA-guided gene regulation and editing

#76
20190345232
2019-11-14

Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody

#77
20190321468
2019-10-24

Selectively altering microbiota for immune modulation

#78
20190316138
2019-10-17

Oligonucleotide compositions with enhanced efficiency

#79
20190316133
2019-10-17

Anti-Fibrinogen Aptamers and Uses Thereof

#80
20190316123
2019-10-17

ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS

#81
20190300878
2019-10-03

METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT

#82
20190242875
2019-08-08

Expression Inhibitor of Inflammation Promoting Factor, Screening Method for Active Ingredient Thereof, Expression Cassette Useful for Said Method, Diagnostic Agent and Diagnosis Method

#83
20190240325
2019-08-08

Selectively altering microbiota for immune modulation

#84
20190233819
2019-08-01

Method of releasing the suppression of egg maturation in economically-important prawn/shrimp species

#85
20190169610
2019-06-06

OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOTIDES AND USES THEREOF

#86
20190062744
2019-02-28

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#87
20190017051
2019-01-17

Oligonucleotide compositions with enhanced efficiency

#88
20190002880
2019-01-03

DOUBLE-STRANDED OLIGONUCLEOTIDES

#89
20180362979
2018-12-20

THERAPEUTIC AND DIAGNOSTIC MOLECULES

#90
20180346909
2018-12-06

System and method for reversible photo-controlled gene silencing

#91
20180327757
2018-11-15

Enhanced protein expression and methods thereof

#92
20180273638
2018-09-27

LIN28- MEDIATED CONTROL OF LET-7 BIOGENESIS

#93
20180259541
2018-09-13

Small molecule biosensors

#94
20180187194
2018-07-05

Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA

#95
20180148718
2018-05-31

Compounds and methods for increasing antisense activity

#96
20180135050
2018-05-17

Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA

#97
20180127747
2018-05-10

SIRNA STRUCTURE FOR MINIMIZING OFF-TARGET EFFECTS AND RELAXING SATURATION OF RNAI MACHINERY AND THE USE THEREOF

#98
20180112225
2018-04-26

Cyanobacterial strains capable of utilizing phosphite

#99
20180087056
2018-03-29

Oligonucleotide compositions with enhanced efficiency

#100
20180080022
2018-03-22

Catalytic strands of minimal hammerhead ribozymes and methods of using the same

#101
20180073026
2018-03-15

NOVEL EXPRESSION REGULATING RNA-MOLECULES AND USES THEREOF

#102
20180036409
2018-02-08

COMPOSITION CONTAINING NUCLEIC ACID MOLECULE STABLY

#103
20180023084
2018-01-25

Disulfide-containing alkyne linking agents

#104
20180023076
2018-01-25

DOUBLE STRAND RNA DELIVERY SYSTEM FOR PLANT-SAP-FEEDING INSECTS

#105
20180010128
2018-01-11

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#106
20180002716
2018-01-04

Compositions and methods thereof for down-regulation of genes following oral delivery of an RNAi molecule bioencapsulated within plant cells

#107
20180002695
2018-01-04

COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS

#108
20170355992
2017-12-14

Factor V/Va-targeting aptamer compositions and methods of using the same

#109
20170355985
2017-12-14

High specificity genome editing using chemically modified guide RNAs

#110
20170321219
2017-11-09

Oligonucleotide compositions with enhanced efficiency

#111
20170268002
2017-09-21

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#112
20170260528
2017-09-14

Delivery of dsRNA to arthropods

#113
20170247410
2017-08-31

Antibacterial antisense oligonucleotide and method

#114
20170211062
2017-07-27

Antisense oligonucleotide compositions

#115
20170159054
2017-06-08

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#116
20170121707
2017-05-04

Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves

#117
20170037402
2017-02-09

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#118
20160355807
2016-12-08

THERAPEUTIC AND DIAGNOSTIC MOLECULES

#119
20160355805
2016-12-08

Double stranded oligonucleotide compounds comprising positional modifications

#120
20160348106
2016-12-01

Alternative export pathways for vector expressed RNA interference

#121
20160340676
2016-11-24

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#122
20160333351
2016-11-17

Bi-Functional Short-Hairpin RNA (Bi-shRNA) Specific for Single-Nucleotide KRAS Mutations

#123
20160319279
2016-11-03

Sequence-specific inhibition of small RNA function

#124
20160304873
2016-10-20

Immunotherapy of cancer

#125
20160272971
2016-09-22

Disulfide-containing alkyne linking agents

#126
20160250165
2016-09-01

Method of modulating the activity of a nucleic acid molecule

#127
20160237439
2016-08-18

Modular RNA regulators and methods

#128
20160237433
2016-08-18

Method for the inhibition of angiogenesis

#129
20160222416
2016-08-04

Orthogonal Cas9 proteins for RNA-guided gene regulation and editing

#130
20160194639
2016-07-07

INHIBITING CANCER METASTASIS

#131
20160177295
2016-06-23

RNA with a combination of unmodified and modified nucleotides for protein expression

#132
20160130584
2016-05-12

Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA

#133
20160073629
2016-03-17

Hydrazinyl lipidoids and uses thereof

#134
20160046932
2016-02-18

Site-specific induction of bimolecular quadruplex-duplex hybrids and methods of using the same

#135
20160017329
2016-01-21

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#136
20160010090
2016-01-14

Bridged bicyclic nucleosides

#137
20160008488
2016-01-14

Vectors and methods for genetic immunization

#138
20150376611
2015-12-31

Oligonucleotide

#139
20150361425
2015-12-17

Antisense antibacterial compounds and methods

#140
20150353937
2015-12-10

Compositions and methods for inhibiting expression of a target gene

#141
20150352046
2015-12-10

Methods and compositions involving miRNA and miRNA inhibitor molecules

#142
20150344909
2015-12-03

Vectors and methods for genetic immunization

#143
20150344883
2015-12-03

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#144
20150344881
2015-12-03

Methods and compositions involving miRNA and miRNA inhibitor molecules

#145
20150337304
2015-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#146
20150322431
2015-11-12

Methods and compositions of improved modified siRNA

#147
20150322428
2015-11-12

COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS

#148
20150315581
2015-11-05

Signal activatable constructs and related components compositions methods and systems

#149
20150275214
2015-10-01

Delivery of dsRNA to arthropods

#150
20150259684
2015-09-17

Orthogonal Cas9 proteins for RNA-guided gene regulation and editing

#151
20150259682
2015-09-17

Gene silencing methods

#152
20150197759
2015-07-16

MUTAGENESIS METHODS

#153
20150166993
2015-06-18

Plant microRNAs and methods of use thereof

#154
20150057333
2015-02-26

Double-stranded oligonucleotides

#155
20150047063
2015-02-12

Delivery of dsRNA to arthropods

#156
20150045414
2015-02-12

Trans-acting RNA switches

#157
20150031103
2015-01-29

Promoter and use thereof

#158
20150018407
2015-01-15

Method for promoting angiogenesis, vascularization or vessel repair or for inhibiting tumor angiogenesis

#159
20150005362
2015-01-01

Methods and compositions for reducing viral genome amounts in a target cell

#160
20150004615
2015-01-01

Small conditional RNAs

#161
20150004221
2015-01-01

Methods and compositions involving miRNA and miRNA inhibitor molecules

#162
20140380528
2014-12-25

Simultaneous gene silencing and suppressing gene silencing in the same cell

#163
20140349292
2014-11-27

OLIGONUCLEOTIDE N3'-->P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USE

#164
20140336370
2014-11-13

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#165
20140329882
2014-11-06

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#166
20140328858
2014-11-06

Lin28-mediated control of let-7 biogenesis

#167
20140315982
2014-10-23

Double-stranded nucleic acid molecule for gene expression control

#168
20140294869
2014-10-02

Immune tolerance inducer

#169
20140287491
2014-09-25

Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA

#170
20140213737
2014-07-31

Antibacterial antisense oligonucleotide and method

#171
20140194490
2014-07-10

Sequence-specific inhibition of small RNA function

#172
20140179003
2014-06-26

Alternative export pathways for vector expressed RNA interference

#173
20140163084
2014-06-12

Methods and compositions for controlling efficacy of RNA silencing

#174
20140128448
2014-05-08

Nucleic acid/polysaccharide complex

#175
20140121364
2014-05-01

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#176
20140106450
2014-04-17

Compositions and methods for inhibiting expression of a target gene

#177
20140057963
2014-02-27

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#178
20130303586
2013-11-14

Oligonucleotide compositions with enhanced efficiency

#179
20130302407
2013-11-14

Bi-functional short-hairpin RNA (bi-shRNA) specific for single-nucleotide mutations

#180
20130253036
2013-09-26

Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA

#181
20130245094
2013-09-19

Aptazyme capable of selective silencing of target miRNA by releasing an antisense sequence in hepatitis C virus-infected cells and use thereof

#182
20130196432
2013-08-01

Biologically active molecules for influencing virus-, bacteria-, parasite-infected cells and/or tumor cells and method for the use thereof

#183
20130053556
2013-02-28

Photocleavable morpholino oligos with integral photolinkers for modulating the activity of any selected gene transcript by exposure to light

#184
20130053432
2013-02-28

In vivo gene sensors

#185
20130045538
2013-02-21

Modified U7 snRNAs for treatment of neuromuscular diseases

#186
20130045520
2013-02-21

Double-stranded oligonucleotides

#187
20120329856
2012-12-27

Methods and compositions for reducing viral genome amounts in a target cell

#188
20120322858
2012-12-20

Compositions and Methods for Inhibiting Expression of a Mutant Gene

#189
20120322856
2012-12-20

Method for treating myocardial infarct

#190
20120322846
2012-12-20

METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF SINGLE AND DOUBLE BLUNT-ENDED siRNA

#191
20120309813
2012-12-06

Delivery of dsRNA to arthropods

#192
20120295963
2012-11-22

AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL

#193
20120288869
2012-11-15

Modulating Gene Expression With agRNA and Gapmers Targeting Antisense Transcripts

#194
20120283319
2012-11-08

Method of inhibiting miR-33 using a modified oligonucleotide

#195
20120276646
2012-11-01

Methods and reagents for analyzing riboswitches using FRET

#196
20120270317
2012-10-25

Alternative export pathways for vector expressed RNA interference

#197
20120252876
2012-10-04

Trans-acting RNA switches

#198
20120238017
2012-09-20

NOVEL SIRNA STRUCTURE FOR MINIMIZING OFF-TARGET EFFECTS AND RELAXING SATURATION OF RNAI MACHINERY AND THE USE THEREOF

#199
20120196925
2012-08-02

Therapeutic and diagnostic molecules

#200
20120195936
2012-08-02

RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION

#201
20120157514
2012-06-21

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#202
20120142763
2012-06-07

NUCLEIC ACID DELIVERY COMPOSITIONS AND METHODS OF USE THEREOF

#203
20120129720
2012-05-24

Aptamer that recognizes peptide

#204
20120122216
2012-05-17

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#205
20120107897
2012-05-03

DOUBLE-STRANDED OLIGONUCLEOTIDES

#206
20120084872
2012-04-05

Methods for producing microRNAs

#207
20120076823
2012-03-29

Vector

#208
20120065248
2012-03-15

Methods and compositions involving miRNA and miRNA inhibitor molecules

#209
20120053333
2012-03-01

Reengineering mRNA primary structure for enhanced protein production

#210
20120041053
2012-02-16

Delivery of dsRNA to arthropods

#211
20120035248
2012-02-09

Method for inhibiting the activity of mir-155

#212
20120035243
2012-02-09

Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders

#213
20120028348
2012-02-02

MULTIPLE RNA POLYMERASE III PROMOTER EXPRESSION CONSTRUCTS

#214
20120022146
2012-01-26

Signal activated molecular delivery

#215
20120016006
2012-01-19

Compositions And Methods For Increasing Cellular Uptake Of RNAi Via SID-1

#216
20110313025
2011-12-22

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#217
20110306758
2011-12-15

Method and materials for the cooperative hybridization of oligonucleotides

#218
20110301229
2011-12-08

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#219
20110301224
2011-12-08

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#220
20110288158
2011-11-24

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#221
20110288148
2011-11-24

Triggered covalent probes for imaging and silencing genetic expression

#222
20110287090
2011-11-24

Compositions and methods for inhibiting expression of a mutant gene

#223
20110263026
2011-10-27

Construction of protein-responsive shRNA/RNAi control system using RNP motif

#224
20110257384
2011-10-20

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#225
20110224277
2011-09-15

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#226
20110223665
2011-09-15

ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND

#227
20110207797
2011-08-25

ENHANCED ANTISENSE OLIGONUCLEOTIDES

#228
20110207217
2011-08-25

Modulation of gene expression by oligomers targeted to chromosomal DNA

#229
20110172292
2011-07-14

ANTIDOTE OLIGOMERS

#230
20110172120
2011-07-14

Compositions and Systems for the Regulation of Genes

#231
20110152352
2011-06-23

SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION

#232
20110152347
2011-06-23

Methods and compositions for controlling efficacy of RNA silencing

#233
20110131668
2011-06-02

IMPROVED GENE SILENCING METHODS

#234
20110124707
2011-05-26

Methods and compositions for reducing viral genome amounts in a target cell

#235
20110111493
2011-05-12

Compositions and methods for inhibiting expression of a target gene

#236
20110110883
2011-05-12

Methods of altering an immune response induced by CpG oligodeoxynucleotides

#237
20110097721
2011-04-28

In vivo gene sensors

#238
20110097328
2011-04-28

Methods and compositions for increasing the activity of inhibitory RNA

#239
20110065908
2011-03-17

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#240
20110039915
2011-02-17

Immunostimulatory siRNA molecules

#241
20100331392
2010-12-30

Antidotes to antisense compounds

#242
20100324121
2010-12-23

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#243
20100324118
2010-12-23

Method for promoting angiogenesis, vascularization or vessel repair

#244
20100317105
2010-12-16

Methods and compositions for controlling efficacy of RNA silencing

#245
20100311820
2010-12-09

Nucleic acid modulators of glycoprotein VI

#246
20100305197
2010-12-02

Conditionally Active Ribozymes And Uses Thereof

#247
20100305186
2010-12-02

METHODS FOR MEDIATING GENE SUPPRESSION

#248
20100303859
2010-12-02

Vectors and method for genetic immunization

#249
20100299771
2010-11-25

MEANS AND METHODS FOR shRNA MEDIATED CONDITIONAL KNOCKDOWN OF GENES

#250
20100298408
2010-11-25

Oligonucleotide Compositions with Enhanced Efficiency

#251
20100292299
2010-11-18

Nucleotide Motifs Providing Localization Elements and Methods of Use

#252
20100291673
2010-11-18

Alternative export pathways for vector expressed RNA interference

#253
20100291194
2010-11-18

Compositions and methods for inhibiting expression of a mutant gene

#254
20100267813
2010-10-21

Method for inhibiting the activity of mir-155

#255
20100266680
2010-10-21

Treatment of cancer using TLR3 agonists

#256
20100263066
2010-10-14

INERT DNA SEQUENCES FOR EFFICIENT VIRAL PACKAGING AND METHODS OF USE

#257
20100255545
2010-10-07

Integrated—ligand-responsive microRNAs

#258
20100249215
2010-09-30

Oligomeric compounds and compositions for use in modulation of pri-miRNAs

#259
20100234281
2010-09-16

Antibacterial antisense oligonucleotide and method

#260
20100234280
2010-09-16

ANTISENSE ANTIBACTERIAL METHOD AND COMPOUND

#261
20100226901
2010-09-09

Genetic control of mammalian cells with synthetic RNA regulatory systems

#262
20100221789
2010-09-02

High potency siRNAS for reducing the expression of target genes

#263
20100221266
2010-09-02

Methods to regulate miRNA processing by targeting Lin-28

#264
20100216868
2010-08-26

AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL

#265
20100190258
2010-07-29

Method of producing recombinant biological products

#266
20100184840
2010-07-22

PRIMARY MICRO RNA EXPRESSION CASSETTE

#267
20100184822
2010-07-22

Method of modulating the activity of a nucleic acid molecule

#268
20100184209
2010-07-22

COMPOSITIONS AND METHODS FOR INHIBITING GENE SILENCING BY RNA INTERFERENCE

#269
20100154072
2010-06-17

siRNA Kinase and Methods of Use

#270
20100136695
2010-06-03

DOUBLE-STRANDED OLIGONUCLEOTIDES

#271
20100113284
2010-05-06

SMALL INTERFERING RNA (SIRNA) TARGET SITE BLOCKING OLIGOS AND USES THEREOF

#272
20100099191
2010-04-22

RNA interference tags

#273
20100093987
2010-04-15

Inhibitor Nucleic Acids

#274
20100088775
2010-04-08

METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME

#275
20100077495
2010-03-25

COMPOSITIONS AND METHODS FOR THE EXPRESSION OF NUCLEIC ACIDS

#276
20100075423
2010-03-25

METHODS AND COMPOSITIONS RELATING TO POLYPEPTIDES WITH RNASE III DOMAINS THAT MEDIATE RNA INTERFERENCE

#277
20100069465
2010-03-18

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#278
20100004436
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#279
20100004435
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#280
20100004434
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#281
20100004318
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#282
20100004317
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#283
20100003758
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#284
20090326051
2009-12-31

Modulation of gene expression through endogenous small RNA targeting of gene promoters

#285
20090326046
2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#286
20090325286
2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#287
20090325285
2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#288
20090325181
2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#289
20090317907
2009-12-24

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#290
20090306177
2009-12-10

Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification

#291
20090298909
2009-12-03

Multiple RNA polymerase III promoter expression constructs

#292
20090298174
2009-12-03

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#293
20090291907
2009-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#294
20090291906
2009-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#295
20090286969
2009-11-19

Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs

#296
20090246833
2009-10-01

Small interfering RNAS as non-specific drugs

#297
20090239816
2009-09-24

Multitargeting Interfering RNAs And Methods Of Their Use And Design

#298
20090217404
2009-08-27

Cell-based RNA interference and related methods and compositions

#299
20090215644
2009-08-27

RNA interference induction element and use thereof

#300
20090210955
2009-08-20

SHRNA AND SIRNA EXPRESSION IN A LIVING ORGANISM UNDER CONTROL OF A CODON-OPTIMIZED REPRESSOR GENE